PATRICIA MCMENAMIN: Open Payments
NPI 1154142818 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 4 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $29 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 1 | $117 |
| Neurocrine BioSciences, Inc. | 2 | $62 |
| Teva Pharmaceuticals USA, Inc. | 1 | $44 |
Products named: CREXONT, INGREZZA, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
